2021年6月，Kojin宣布完成6000万美元的A轮融资，用于加速对铁死亡敏感的耐药肿瘤的药物研发。该轮融资由凯辉基金、Polaris和Newpath领投，Bayer“飞跃计划”、AbbVie等机构共同参与。时隔4年，这家曾被列为“2021年度十大最值得关注的初创企业”由于资金链断裂 ...

Kojin Therapeutics Inc. has shared that it plans to wind down its operations in the coming months. The Boston-based biotech launched in mid-2021 and since January 2024 has been led by Harvey ...

It's unclear how many employees have been impacted. Story Feb. 14 - Kojin Therapeutics: Boston biotech Kojin is winding down operations over the next few months, according to a LinkedIn status ...

“We are looking to produce a sustainable source of food in Japan,” said Fumihiko Kojin, president of Taiyo Green Energy. It is one of an increasing number of Japanese businesses getting into ...